Latest news
TG Therapeutics, Inc. (TGTX) Stock Analysis: 31.52% Potential Upside Beckons Investors - DirectorsTalk InterviewsDirectorsTalk Interviews · Mon, 03 Aug 2026 09:24:45 GMTAlnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: 87.96% Potential Upside Beckons Investors - DirectorsTalk InterviewsDirectorsTalk Interviews · Mon, 03 Aug 2026 09:21:42 GMTKoninklijke Philips N.V. (PHG) Stock Analysis: 22.47% Potential Upside Beckons Investors - DirectorsTalk InterviewsDirectorsTalk Interviews · Mon, 03 Aug 2026 09:10:22 GMTOric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 77.77% Potential Upside Beckons Biotech Investors - DirectorsTalk InterviewsDirectorsTalk Interviews · Fri, 31 Jul 2026 09:22:53 GMT